French biotech companies divide investors on Paris market

Biotech companies listed on the stock exchange are subject to heated debates among investors on specialized forums.

Published 12sem1 sourceMajorupdated 5j

≈ 20sSpeed

The fact

Genfit, Biophytis and OSE Immunotherapeutics experience price swings linked to clinical development announcements.

Small-cap stocks remain volatile, torn between therapeutic hopes and execution risks.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on April 24, 2026